Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 6;67(5):ezae352.
doi: 10.1093/ejcts/ezae352.

2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP

Collaborators, Affiliations

2024 EACTS/EACTAIC Guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP

Filip P A Casselman et al. Eur J Cardiothorac Surg. .
No abstract available

Keywords: Guidelines; anticoagulation; bleeding; blood transfusion; cardiac surgery; coagulation factors; evidence based practice; haemostasis; patient blood management.

PubMed Disclaimer

Figures

None
Central Illustration. Multidisciplinary patient blood management approach. CPB: cardiopulmonary bypass; DAPT: dual antiplatelet therapy; DDAVP: desmopressin; FFP: fresh-frozen plasma; PCC: prothrombin complex concentrate; POC: point-of-care; PRBCs: packed red blood cells.
Figure 1:
Figure 1:
Management of antiplatelet therapy in patients having coronary artery bypass grafting surgery. aComplex and redo surgery, severe renal insufficiency, congenital and acquired bleeding and anaemia. bPlatelet function testing in urgent cases may be considered to optimize the timing and safety of surgery. cRecent stent implant, recent thromboembolic event and alarming angiographic results. ASA: acetylsalicylic acid; DAPT: dual antiplatelet therapy; GPIIb/IIIa: glycoprotein IIb/IIIa.
Figure 2:
Figure 2:
Management of oral anticoagulation in patients with an indication for preoperative bridging and/or postoperative anticoagulation therapy. aPatients with mechanical prosthetic heart valve, atrial fibrillation with rheumatic valvular disease, acute thrombotic event within the prior 12 weeks, acquired or congenital pro-thrombotic defects and left ventricular apex thrombus. bDiscontinuation of LMWH depends on the type and dosing of the medication. cFor dabigatran, discontinuation should be prolonged to > 48 h if the estimated glomerular filtration rate (eGFR) is 50–80 ml/min/1.73 m2 and ≥96 h if eGFR is <50 ml/min/1.73 m2; it is contraindicated if the eGFR is <30 ml (min/1.73 m2 for other DOACs, discontinuation should be ≥ 72 h if the eGFR is 30–50 ml/min/1.73 m2 and > 96 h if the eGFR is 15–30 ml/min/1.73 m2. dBridging for VKA only with UFH/LMWH should be discontinued once the INR reaches the adequate target range, confirmed by 2 consecutive tests. DOAC: direct oral anticoagulant; INR: International normalized ratio; LMWH: low-molecular-weight heparin; UFH, unfractionated heparin; VKA: vitamin K antagonists.
Figure 3:
Figure 3:
Key messages from the Multidisciplinary Patient Blood Management Guidelines for Adult Cardiac Surgery. CPB: cardiopulmonary bypass; DDAVP: desmopressin; DOAC: direct oral anticoagulant; EPO: erythropoietin; FFP: fresh-frozen plasma; PBM: patient blood management; PCC: prothrombin complex concentrate; POC: point-of-care; PRBCs: packed red blood cells; rFVIIa: recombinant factor VIIa; VKAs: vitamin-K antagonists.

Comment in

References

    1. Pagano D, Milojevic M, Meesters MI, Benedetto U, Bolliger D, von Heymann C, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg. 2018;53:79–111. - PubMed
    1. Sousa-Uva M, Head SJ, Thielmann M, Cardillo G, Benedetto U, Czerny M, et al. Methodology manual for European Association for Cardio-Thoracic Surgery (EACTS) clinical guidelines. Eur J Cardiothorac Surg. 2015;48:809–16. - PubMed
    1. Shaneyfelt TM, Centor RM.. Reassessment of clinical practice guidelines: go gently into that good night. Jama. 2009;301:868–9. - PubMed
    1. Böhmer AB, Wappler F, Zwissler B.. Preoperative risk assessment—from routine tests to individualized investigation. Dtsch Arztebl Int. 2014;111:437–45. - PMC - PubMed
    1. Matejic-Spasic M, Hassan K, Thielmann M, Geidel S, Storey RF, Schmoeckel M, et al. Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery-a systematic review. J Thorac Dis. 2022;14:3030–44. - PMC - PubMed